Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

  1. Ramos Elbal, E.
  2. Fuster, J.L.
  3. Campillo, J.A.
  4. Galera, A.M.
  5. Cortés, M.B.
  6. Llinares, M.E.
  7. Jiménez, I.
  8. Plaza, M.
  9. Banaclocha, H.M.
  10. Galián, J.A.
  11. Blanquer Blanquer, M.
  12. Martínez Sánchez, M.V.
  13. Muro, M.
  14. Minguela, A.
Journal:
Clinical and Translational Oncology

ISSN: 1699-3055 1699-048X

Year of publication: 2023

Volume: 25

Issue: 5

Pages: 1446-1454

Type: Article

DOI: 10.1007/S12094-022-03042-Z GOOGLE SCHOLAR